FR07C0023I2 - DNA ENCODING HUMAN PAPILLOMA VIRUS TYPE 18 - Google Patents

DNA ENCODING HUMAN PAPILLOMA VIRUS TYPE 18

Info

Publication number: FR07C0023I2
Authority: FR; France
Prior art keywords: dna encoding; virus type; encoding human; papilloma virus; human papilloma
Prior art date: 1995-03-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR07C0023C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-22

Filing date

2007-03-20

Publication date

2012-08-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR07C0023(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-03-22 Priority claimed from US08/409,122 external-priority patent/US5820870A/en

1995-03-22 Priority claimed from US08/408,669 external-priority patent/US5840306A/en

2007-03-20 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

2007-04-27 Publication of FR07C0023I1 publication Critical patent/FR07C0023I1/fr

2012-08-03 Application granted granted Critical

2012-08-03 Publication of FR07C0023I2 publication Critical patent/FR07C0023I2/en

Status Active legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Virology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Mycology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FR07C0023C 1995-03-22 2007-03-20 DNA ENCODING HUMAN PAPILLOMA VIRUS TYPE 18 Active FR07C0023I2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/409,122 US5820870A (en)	1995-03-22	1995-03-22	Recombinant human papillomavirus type 18 vaccine
US08/408,669 US5840306A (en)	1995-03-22	1995-03-22	DNA encoding human papillomavirus type 18
PCT/US1996/003649 WO1996029413A2 (en)	1995-03-22	1996-03-18	Dna encoding human papilloma virus type 18

Publications (2)

Publication Number	Publication Date
FR07C0023I1 FR07C0023I1 (en)	2007-04-27
FR07C0023I2 true FR07C0023I2 (en)	2012-08-03

Family

ID=27020342

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR07C0023C Active FR07C0023I2 (en)	1995-03-22	2007-03-20	DNA ENCODING HUMAN PAPILLOMA VIRUS TYPE 18

Country Status (22)

Country	Link
EP (2)	EP0817851B9 (en)
JP (1)	JPH11502704A (en)
KR (1)	KR100430698B1 (en)
CN (1)	CN1100876C (en)
AT (1)	ATE259879T1 (en)
AU (1)	AU714533B2 (en)
CA (1)	CA2215834C (en)
CZ (1)	CZ291242B6 (en)
DE (4)	DE122007000025I1 (en)
DK (1)	DK0817851T5 (en)
EA (1)	EA001092B1 (en)
ES (1)	ES2213772T3 (en)
FR (1)	FR07C0023I2 (en)
HU (1)	HU223761B1 (en)
IL (1)	IL117459A (en)
NL (3)	NL300272I1 (en)
NO (1)	NO322254B1 (en)
NZ (1)	NZ305188A (en)
PL (1)	PL184022B1 (en)
PT (1)	PT817851E (en)
SK (1)	SK284281B6 (en)
WO (1)	WO1996029413A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9621091D0 (en)	1996-10-09	1996-11-27	Fondation Pour Le Perfectionem	Attenuated microorganisms strains and their uses
ZA982950B (en)	1997-04-08	1998-10-19	Merck & Co Inc	Stabilized human papillomavirus formulations
CA2286294A1 (en) *	1997-04-08	1998-10-15	Merck & Co., Inc.	Stabilized human papillomavirus formulations
EP1105466B1 (en) *	1998-08-14	2006-04-26	Merck & Co., Inc.	Process for purifying human papillomavirus virus-like particles
AUPP765398A0 (en)	1998-12-11	1999-01-14	University Of Queensland, The	Treatment of papillomavirus infections
EP1150712B1 (en)	1999-02-05	2008-11-05	Merck & Co., Inc.	Human papilloma virus vaccine formulations
FR2795074A1 (en) *	1999-05-21	2000-12-22	Inst Nat Sante Rech Med	POLYPEPTIDES TRANSPORTING AMINO ACIDS, IN PARTICULAR GLUTAMATE, AND METHODS OF SCREENING INHIBITOR OR ACTIVATOR COMPOUNDS OF TRANSPORT ACTIVITY
MY140664A (en) *	2003-09-29	2010-01-15	Merck Sharp & Dohme	Optimized expression of hpv 45 l1 in yeast
TWI457133B (en)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	Novel composition
CN101293918B (en)	2007-04-29	2013-03-27	北京万泰生物药业股份有限公司	Shorten human papilloma virus 16 type L1 protein
CN101570571B (en) *	2007-04-29	2012-07-11	北京万泰生物药业股份有限公司	Truncated Human Papillomavirus Type 18 L1 Protein
CN101440373B (en) *	2007-11-23	2012-09-05	上海泽润生物科技有限公司	Truncated 18 type human papilloma virus major capsid protein L1 gene
WO2010149752A2 (en) *	2009-06-25	2010-12-29	Glaxosmithline Biologicals S.A.	Novel compositions
JP6001064B2 (en) *	2011-06-15	2016-10-05	チュンアンユニバーシティーインダストリーアカデミックコアポレイションファウンデイション	Method for improving production yield of human papillomavirus L1 protein
CA2866582A1 (en)	2012-03-18	2013-09-26	Brigitte Desiree Alberte Colau	Method of vaccination against human papillomavirus
CN108276491B (en) *	2018-02-05	2021-01-12	南京薇熙生物医药科技有限公司	Monoclonal antibody capable of specifically recognizing HPV18L1 protein and application thereof
MX2022000778A (en)	2019-07-19	2022-02-14	Sinocelltech Ltd	CHIMERIC PROTEIN L1 OF THE HUMAN PAPILLOMA VIRUS.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3625257A1 (en) *	1986-07-23	1988-02-04	Behringwerke Ag	EXPRESSION PRODUCTS OF THE HUMAN PAPILLOMVIRUS TYPE 16 AND 18, FOR THESE PROTEINS, SPECIFIC ANTIBODIES AND THESE ANTIBODIES OR. CORRESPONDING DNA-CONTAINING DIAGNOSTICS
DE4015044A1 (en) *	1990-05-10	1991-11-14	Behringwerke Ag	SEROREACTIVE EPITOPE ON PROTEINS OF THE HUMAN PAPILLOMAVIRUS (HPV) 18
DE122007000017I1 (en) *	1991-07-19	2007-07-26	Univ Queensland	Vaccines against papillomavirus
DE122007000094I1 (en) *	1992-06-25	2008-03-27		PAPILLOMA VIRUS VACCINE
US5437951A (en) *	1992-09-03	1995-08-01	The United States Of America As Represented By The Department Of Health And Human Services	Self-assembling recombinant papillomavirus capsid proteins
ES2263406T3 (en) *	1993-03-09	2011-06-06	The University Of Rochester	PRODUCTION OF THE CAPSIDE L1 PROTEIN OF THE HPV-11 HUMAN PAPILOMAVIRUS AND VIRUS TYPE PARTICLES.

1996
- 1996-03-13 IL IL11745996A patent/IL117459A/en active Protection Beyond IP Right Term
- 1996-03-18 DE DE1996631586 patent/DE122007000025I1/en active Pending
- 1996-03-18 WO PCT/US1996/003649 patent/WO1996029413A2/en active IP Right Grant
- 1996-03-18 ES ES96909743T patent/ES2213772T3/en not_active Expired - Lifetime
- 1996-03-18 PT PT96909743T patent/PT817851E/en unknown
- 1996-03-18 AU AU53141/96A patent/AU714533B2/en not_active Expired
- 1996-03-18 SK SK1278-97A patent/SK284281B6/en not_active IP Right Cessation
- 1996-03-18 KR KR1019970706580A patent/KR100430698B1/en not_active IP Right Cessation
- 1996-03-18 CN CN96194121A patent/CN1100876C/en not_active Expired - Lifetime
- 1996-03-18 DK DK96909743T patent/DK0817851T5/en active
- 1996-03-18 CA CA002215834A patent/CA2215834C/en not_active Expired - Lifetime
- 1996-03-18 EP EP96909743A patent/EP0817851B9/en not_active Expired - Lifetime
- 1996-03-18 DE DE200712000030 patent/DE122007000030I1/en active Pending
- 1996-03-18 EA EA199700256A patent/EA001092B1/en not_active IP Right Cessation
- 1996-03-18 JP JP8528535A patent/JPH11502704A/en active Pending
- 1996-03-18 AT AT96909743T patent/ATE259879T1/en active
- 1996-03-18 NZ NZ305188A patent/NZ305188A/en not_active IP Right Cessation
- 1996-03-18 EP EP04075256A patent/EP1422294A1/en not_active Withdrawn
- 1996-03-18 CZ CZ19972936A patent/CZ291242B6/en not_active IP Right Cessation
- 1996-03-18 PL PL96322333A patent/PL184022B1/en unknown
- 1996-03-18 DE DE200712000031 patent/DE122007000031I1/en active Pending
- 1996-03-18 HU HU9801334A patent/HU223761B1/en active IP Right Grant
- 1996-03-18 DE DE69631586T patent/DE69631586T9/en active Active
1997
- 1997-09-19 NO NO19974322A patent/NO322254B1/en not_active IP Right Cessation
2007
- 2007-03-14 NL NL300272C patent/NL300272I1/en unknown
- 2007-03-14 NL NL300273C patent/NL300273I1/en unknown
- 2007-03-14 NL NL300271C patent/NL300271I1/en unknown
- 2007-03-20 FR FR07C0023C patent/FR07C0023I2/en active Active

Also Published As

Publication number	Publication date
NO974322L (en)	1997-11-24
DE122007000025I1 (en)	2007-07-12
CZ291242B6 (en)	2003-01-15
IL117459A0 (en)	1996-07-23
EA001092B1 (en)	2000-10-30
DK0817851T5 (en)	2004-10-25
NL300271I1 (en)	2007-05-01
MX9707208A (en)	1997-11-29
NZ305188A (en)	1999-11-29
HU223761B1 (en)	2005-01-28
HUP9801334A3 (en)	1999-04-28
DE69631586D1 (en)	2004-03-25
JPH11502704A (en)	1999-03-09
WO1996029413A3 (en)	1996-11-28
IL117459A (en)	2005-11-20
DE122007000030I1 (en)	2007-07-19
CN1100876C (en)	2003-02-05
PT817851E (en)	2004-06-30
DE69631586T9 (en)	2005-06-16
CA2215834C (en)	2007-06-12
EA199700256A1 (en)	1999-06-24
DE122007000031I1 (en)	2007-07-19
HUP9801334A2 (en)	1998-08-28
EP0817851B1 (en)	2004-02-18
EP0817851B9 (en)	2004-08-18
PL184022B1 (en)	2002-08-30
NL300272I1 (en)	2007-05-01
CA2215834A1 (en)	1996-09-26
KR100430698B1 (en)	2004-07-15
FR07C0023I1 (en)	2007-04-27
CN1185176A (en)	1998-06-17
DK0817851T3 (en)	2004-08-16
NL300273I1 (en)	2007-05-01
EP1422294A1 (en)	2004-05-26
PL322333A1 (en)	1998-01-19
NO322254B1 (en)	2006-09-04
SK284281B6 (en)	2004-12-01
AU5314196A (en)	1996-10-08
WO1996029413A2 (en)	1996-09-26
CZ293697A3 (en)	1998-02-18
EP0817851A2 (en)	1998-01-14
AU714533B2 (en)	2000-01-06
DE69631586T2 (en)	2005-01-27
ES2213772T3 (en)	2004-09-01
ATE259879T1 (en)	2004-03-15
SK127897A3 (en)	1998-07-08
NO974322D0 (en)	1997-09-19

Publication	Publication Date	Title
FR07C0023I2 (en)	2012-08-03	DNA ENCODING HUMAN PAPILLOMA VIRUS TYPE 18
DE69634533D1 (en)	2005-05-04	disposable
FI971176A0 (en)	1997-03-20	DNA photo-cleavage by texapyrins
TR199700447A3 (en)	1997-12-21	"Polymerization catalyst"
FI963201A (en)	1996-08-15	Antiparasitic substances
ATE209045T1 (en)	2001-12-15	HEPATITIS B VACCINE
FI98872B (en)	1997-05-15	Improved step-adjustable filter
DE69622331D1 (en)	2002-08-22	Blender
ZA962245B (en)	1996-09-30	Dna encoding human papillomavirus type 18
PT1019358E (en)	2003-09-30	3,3-DIARILPROPILLAMINES ITS USE AND PREPARATION
FI964423A0 (en)	1996-11-04	DNA sequences
PL319294A1 (en)	1997-08-04	Dna encoding the human papilloma virus of 6 a type
BR9508433A (en)	1998-07-14	Peptides
DE69509766D1 (en)	1999-06-24	MICROEMULSIONS
DE69612897D1 (en)	2001-06-28	Micro file
DK0821057T3 (en)	2007-10-08	baker's yeast
IT1276074B1 (en)	1997-10-24	DISPOSABLE RECTOSCOPE
DE69606985D1 (en)	2000-04-13	IMPROVED POTENTIOMETER
DE69730411D1 (en)	2004-09-30	METASTASES INDUCING DNA'S
KR960028201U (en)	1996-09-17	Improved mat
FR2732339B1 (en)	1998-01-30	NOVEL PHOTO-INDUCTION DNA CLAVING AGENTS
KR970005245A (en)	1997-02-19	Articulator
KR970009717U (en)	1997-03-27	Catalyst Cleaner
BR7501397U (en)	1997-09-16	Disposable mat
KR960032378U (en)	1996-10-24	V's Knob Structure